Biomedicines (Jun 2024)

Quality of Life in Follow-Up up to 9 Months after COVID-19 Hospitalization among the Polish Population—A Prospective Single Center Study

  • Ewa Pietruszka-Wałęka,
  • Michał Rząd,
  • Renata Rożyńska,
  • Piotr Miklusz,
  • Emilia Zieniuk-Lesiak,
  • Magdalena Żabicka,
  • Karina Jahnz-Różyk

DOI
https://doi.org/10.3390/biomedicines12061282
Journal volume & issue
Vol. 12, no. 6
p. 1282

Abstract

Read online

The consequences of COVID-19 constitute a significant burden to healthcare systems worldwide. Conducting an HRQoL assessment is an important aspect of the evaluation of the impact of the disease. The aim of this study was to investigate the prevalence of persistent symptoms and their impact on HRQoL and health status in COVID-19 convalescents. The study group consists of 46 patients who required hospitalization due to respiratory failure and who were subsequently evaluated 3 and 9 months after hospital discharge. At the follow-up visits, the patients were asked to assess their HRQoL using the EQ-5D-5L questionnaire. The results of chest CT, 6MWT, as well as the severity of the course of COVID-19 were also considered in the analysis. The obtained results have identified fatigue as the most common persistent symptom. The majority of the convalescents reported an impairment of HRQoL in at least one domain (80% and 82% after 3 and 9 months, respectively), of which the most common was that of pain/discomfort. The presence of ongoing symptoms may affect HRQoL in particular domains. The 6MWT outcome correlates with HRQoL 3 months after hospital discharge. Therefore, it may be useful in identifying patients with reduced HRQoL, allowing early interventions aimed at its improvement.

Keywords